A novel biguanide-derivative promotes NEDD4-mediated FGFR1 ubiquitination through BMI1 to overcome osimertinib resistance in NSCLC
1Department of Pharmacy and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China
2Department of Oncology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410013, China
3Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Institute of Interdisciplinary Studies, Cancer Institute, School of Pharmaceutical Sciences, Health Science Center, Hunan Normal University, Changsha 410013, China
4Department of Oncological Surgery, Shanghai Chest Hospital, Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200030, China
5Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha 410011, China
收起